Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.
about
Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patientsLoss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesisCommon sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer riskMolecular pathology of prostate cancerMesenchymal stem cells as a vector for the inflammatory prostate microenvironmentProstatic inflammation induces fibrosis in a mouse model of chronic bacterial infectionMYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitorsTargeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeGermline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer riskAssociation between NQO1 C609T polymorphism and prostate cancer riskNormal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factorGSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cellsTransient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late lifeChanges in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life spanDifferential proteomics in the aging Noble rat ventral prostateGSTP1 Ile105Val polymorphism and prostate cancer risk: evidence from a meta-analysisMolecular markers in prostate cancer. Part I: predicting lethality.The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.Molecular genetics of human prostate cancer.Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1.p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.Integrative molecular concept modeling of prostate cancer progression.Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat.Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assayCandidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.Prostate cancer and inflammation: the evidence.Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants.Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results.Testosterone regulates tight junction proteins and influences prostatic autoimmune responsesMechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.Vitamin D metabolism and action in the prostate: implications for health and disease.Gene expression profiles and differential cytoglobin expression in atrophy and adenocarcinoma of the prostate.Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.
P2860
Q21245049-A501C59A-11E9-4F33-94E6-7A4C438E4B77Q24314483-FB7A5D30-0B23-428B-AAD0-6E6C15E9726CQ24615293-4851A316-A732-4AF8-90E4-A967F1203E1DQ24672410-929BBB44-F437-46F3-A1EA-53DE486F4A2AQ26853374-2A0F52F4-597E-4979-A1EB-C4283E5EA3B8Q27321863-47476A5D-B7B0-40E4-8A95-5A1A78656DECQ27350187-C17A8C59-C47B-455D-BBE2-893AA084E03AQ28066522-391463E6-B9C9-4C83-BB29-1A1B944A26DCQ28203206-60D751F6-B807-47D9-8528-AA8BCE802129Q28240340-1677B159-C6F0-47FC-A440-9775C2B3D064Q28345285-FEE07499-1289-44B3-A554-6AB59FBB6E41Q28363395-32393E32-8410-4300-B943-CEBAD62320BCQ28505915-832BAD93-D3F6-4717-B4C3-04A902E3C1F3Q28576140-A082321B-1E43-4C1F-A33C-1289DBCFCC77Q28576987-5008C903-5345-4AF3-BFE4-6B9306C109DFQ28681793-11BA8CA2-CDDD-402C-870F-369975CDCE9BQ30373669-81AB0657-8308-41C8-979E-49942E78ABC7Q30438926-15D7CDDA-221F-4131-9AEC-44B4247D7A0CQ30617117-75762916-5479-4938-BB47-A4D88EFC0396Q30855755-C8A9A416-77C7-4E48-9429-40EF4A7472E3Q31039228-C3E080D4-74FA-4346-B2F0-65EFF6F692B1Q31074064-6BB02FAC-3E8B-424D-A568-283FD8D5DFE6Q31115813-2FD1E126-C48D-4649-9962-58A24283A9D7Q32048236-77EB495B-D0A9-4D79-895C-98A4ADE318D2Q33266777-3226EC37-DDAC-468D-872A-E6C3FE621720Q33295021-BC3D838F-E9CD-4A73-87E6-09B47F0FF51FQ33299656-4D7C6367-F42B-479D-B1CB-6802DA2843C1Q33490254-046792F5-75FA-47D8-A3B0-07771E3A5FE4Q33642321-6B2036D0-8905-485A-A2EC-A5A578308701Q33774556-C9D6B982-DB5B-4A2F-BB4F-F03CE94FA902Q33806328-5894673C-5FE6-4168-8E6D-A113E1FFCB44Q33816335-BE9A7ADF-3811-4E6D-8B5A-7375649E9BCCQ33821738-8203D96D-571E-4F51-95F0-F167F0FB6BCBQ33949736-73A7DCD0-080A-42BA-9614-F37B459EFC6CQ33962057-1E59CB37-5DB6-4D57-B69D-B66B50E4DC61Q34013858-52DD2E8F-D2B7-4BFB-954C-E485C9B1C095Q34027269-F75E9021-B5B5-4DA2-95C8-FEC39C1C1A3AQ34057058-9B78D671-0D1D-4F75-BE5E-5F5DF8CE34C1Q34058710-7881CFA1-0A83-4A9E-B8F8-F5C7AA989A60Q34064040-4A62EBF3-18E5-4B28-8674-F60CCCC9C5B9
P2860
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Proliferative inflammatory atr ...... for prostatic carcinogenesis.
@en
type
label
Proliferative inflammatory atr ...... for prostatic carcinogenesis.
@en
prefLabel
Proliferative inflammatory atr ...... for prostatic carcinogenesis.
@en
P2093
P2860
P1476
Proliferative inflammatory atr ...... for prostatic carcinogenesis.
@en
P2093
A M De Marzo
J I Epstein
V L Marchi
W G Nelson
P2860
P304
P356
10.1016/S0002-9440(10)65517-4
P407
P577
1999-12-01T00:00:00Z